ATE182587T1 - Derivate von 6-substituierten azyklischen pyrimidin-nukleosiden und diese als wirkstoff enthaltende antivirale mittel - Google Patents

Derivate von 6-substituierten azyklischen pyrimidin-nukleosiden und diese als wirkstoff enthaltende antivirale mittel

Info

Publication number
ATE182587T1
ATE182587T1 AT90402693T AT90402693T ATE182587T1 AT E182587 T1 ATE182587 T1 AT E182587T1 AT 90402693 T AT90402693 T AT 90402693T AT 90402693 T AT90402693 T AT 90402693T AT E182587 T1 ATE182587 T1 AT E182587T1
Authority
AT
Austria
Prior art keywords
alkyl
atom
group
hydrogen atom
oxygen
Prior art date
Application number
AT90402693T
Other languages
English (en)
Inventor
Tadashi Miyasaka
Hiromichi Tanaka
Clercq Erik Desire Alice De
Masanori Baba
Richard Thomas Walker
Masaru Ubasawa
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2200895A external-priority patent/JPH0751567B2/ja
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE182587T1 publication Critical patent/ATE182587T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/58Two sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT90402693T 1989-09-29 1990-09-28 Derivate von 6-substituierten azyklischen pyrimidin-nukleosiden und diese als wirkstoff enthaltende antivirale mittel ATE182587T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25453189 1989-09-29
JP5970090 1990-03-09
JP2200895A JPH0751567B2 (ja) 1989-09-29 1990-07-27 6―置換アシクロピリミジンヌクレオシド誘導体及び該誘導体を有効成分とする抗ウイルス剤

Publications (1)

Publication Number Publication Date
ATE182587T1 true ATE182587T1 (de) 1999-08-15

Family

ID=27296972

Family Applications (2)

Application Number Title Priority Date Filing Date
AT90402693T ATE182587T1 (de) 1989-09-29 1990-09-28 Derivate von 6-substituierten azyklischen pyrimidin-nukleosiden und diese als wirkstoff enthaltende antivirale mittel
AT97110658T ATE222891T1 (de) 1989-09-29 1990-09-28 6-substituierte acylopyrimidin-nucleoside- derivate und diese als wirksamen stoff enthaltende antivirusmittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97110658T ATE222891T1 (de) 1989-09-29 1990-09-28 6-substituierte acylopyrimidin-nucleoside- derivate und diese als wirksamen stoff enthaltende antivirusmittel

Country Status (10)

Country Link
EP (2) EP0829476B1 (de)
AT (2) ATE182587T1 (de)
CA (1) CA2026226C (de)
DD (1) DD299297A5 (de)
DE (2) DE69033998T2 (de)
DK (2) DK0420763T3 (de)
ES (2) ES2134758T3 (de)
GR (1) GR3031231T3 (de)
HU (1) HU205917B (de)
PH (1) PH30766A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278167A (en) * 1992-05-13 1994-01-11 Brown University Research Foundation 6-pyridyl substituted pyrimidine derivatives
EP0631783A1 (de) * 1993-06-03 1995-01-04 Mitsubishi Chemical Corporation Antivirale Kombinationen von 2',3-Di-deoxyribonukleosiden mit 6-benzyl-1-ethoxy-methyl-5-substituierten Uracil-Derivaten
KR0151811B1 (ko) * 1993-12-21 1998-10-15 강박광 신규한 항바이러스성 2,4-피리미딘디온 유도체 및 그의 제조방법
EP0748316B1 (de) * 1994-02-28 2002-05-08 Sunkyong Industries Co., Ltd. Pyrimidin-acyclonukleosid-derivate
DE69628750T2 (de) * 1996-02-22 2004-04-29 Samjin Pharm, Co., Ltd. Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten
US5998411A (en) * 1998-03-17 1999-12-07 Hughes Institute Heterocyclic nonnucleoside inhibitors of reverse transcriptase
FR2781219B1 (fr) 1998-07-16 2000-08-25 Synthelabo Procede pour la preparation de 5-(1-methylethyl)-6-(phenylmethyl)pyrimidine-2,4 (1h, 3h) -dione
US6136335A (en) 1998-12-31 2000-10-24 Hughes Institute Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity
WO2000051990A1 (en) * 1999-03-04 2000-09-08 Korea Research Institute Of Chemical Technology Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
KR20000065885A (ko) 1999-04-10 2000-11-15 최승주 항바이러스성 피리미딘다이온 유도체 및 그 제조방법
US6545152B1 (en) 2000-07-18 2003-04-08 Parker Hughes Institute R-isomers of nonnucleoside inhibitors
US6689793B2 (en) 2000-12-06 2004-02-10 Parker Hughes Institute Piperidinylethyl-, phenoxyethyl-, and β-fluorophenethyl-substituted thiourea compounds with potent anti-HIV activity
FR2820135B1 (fr) * 2001-01-29 2005-01-14 Univ Geneve Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation
US6911450B1 (en) 2001-01-29 2005-06-28 Universite De Geneve Pyrimidine acyclonucleoside derivatives, preparation method and use thereof
AU2003205536A1 (en) * 2002-01-11 2003-07-24 Statens Serum Institut Anti-retroviral 5,6-disubstituted acyclopyrimidine nucleoside derivatives
MXPA05001783A (es) 2002-08-13 2005-04-25 Warner Lambert Co Derivados de pirimidina-2,4-diona como inhibidores de las metaloproteinasas de matriz.
HRPK20090508B3 (hr) 2009-09-25 2012-12-31 Sveučilište u Zagrebu Novi 6-supstituirani derivati pirimidina
CN115960148B (zh) * 2021-08-27 2023-12-12 南京知和医药科技有限公司 一种新型的胞苷衍生物及其药物组合物和用途
CN115554303B (zh) * 2021-09-18 2024-07-09 上海科技大学 一种三环类化合物、其制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3497515A (en) * 1966-02-04 1970-02-24 Du Pont 3,5,6-substituted uracils
DE2126148A1 (en) * 1971-05-26 1972-12-07 Farbenfabriken Bayer Ag, 5090 Leverkusen Prepn of uracil derivs - useful as plant - protection agents and their inters
DE2142317A1 (de) * 1971-08-24 1973-03-01 Bayer Ag Hypnotisches mittel
DE3206197A1 (de) * 1982-02-20 1983-09-01 Henkel KGaA, 4000 Düsseldorf Uracil-derivate als antiseborrhoische zusaetze fuer kosmetische mittel
JPS61205261A (ja) * 1985-03-08 1986-09-11 Sagami Chem Res Center 6―置換―5―フルオロウラシル誘導体
ES2013664A6 (es) * 1988-03-31 1990-05-16 Mitsubishi Chem Ind Un procedimiento para preparar derivados de nucleosidos de aciclopiramidina sustituidos en la posicion 6.

Also Published As

Publication number Publication date
CA2026226A1 (en) 1991-03-30
EP0420763A3 (en) 1991-09-18
EP0829476A2 (de) 1998-03-18
DE69033998D1 (de) 2002-10-02
HU205917B (en) 1992-07-28
DK0829476T3 (da) 2002-11-11
PH30766A (en) 1997-10-17
AU6326290A (en) 1991-04-11
ES2134758T3 (es) 1999-10-16
DK0420763T3 (da) 2000-03-06
EP0829476B1 (de) 2002-08-28
EP0420763B1 (de) 1999-07-28
EP0420763A2 (de) 1991-04-03
DE69033223D1 (de) 1999-09-02
CA2026226C (en) 2003-08-19
DE69033223T2 (de) 1999-12-23
ES2177861T3 (es) 2002-12-16
HUT55006A (en) 1991-04-29
GR3031231T3 (en) 1999-12-31
AU642906B2 (en) 1993-11-04
ATE222891T1 (de) 2002-09-15
DD299297A5 (de) 1992-04-09
HU906019D0 (en) 1991-03-28
EP0829476A3 (de) 1999-02-24
DE69033998T2 (de) 2003-05-08

Similar Documents

Publication Publication Date Title
ATE182587T1 (de) Derivate von 6-substituierten azyklischen pyrimidin-nukleosiden und diese als wirkstoff enthaltende antivirale mittel
DE69021472D1 (de) Pyrazolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellung.
IL109395A0 (en) Heterocyclic derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE69230163D1 (de) Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
HU9301084D0 (en) (1,2,4-oxadozolyl-phenoxi-alkyl)-isoxazole derivatives and their application as anti-viral agent
KR910006242A (ko) 6-치환된 아시클로피리미딘 뉴클레오시드 유도체 및 이를 활성 성분으로 함유하는 항비루스제
KR900700463A (ko) 6-치환 비환식 피리미딘 뉴클레오시드 유도체 및 그 유도체를 유효성분으로 하는 항 비루스재
FI910303A0 (fi) Derivat av tiazolidin med blodtrycksnedsaenkande effekt och terapeutisk anvaendning av dessa.
MX9203939A (es) Derivados de hidroisoquinolina y composiciones farmaceuticas que los contienen.
AU664412B2 (en) 4H-naphtho(1,2b)pyran derivatives and their use as antiproliferative agents
AU3014592A (en) Systemic control of parasites
MX9202994A (es) Derivados de 2-aminoacetamida.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee